- Home
- KZIA vs DSS Comparison
KZIA vs DSS Comparison
Compare KZIA & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- DSS
- Stock Information
- Founded
- KZIA 1994
- DSS 1984
- Country
- KZIA Australia
- DSS United States
- Employees
- KZIA N/A
- DSS N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- KZIA Health Care
- DSS Consumer Discretionary
- Exchange
- KZIA Nasdaq
- DSS Nasdaq
- Market Cap
- KZIA 5.1M
- DSS 8.9M
- IPO Year
- KZIA 1999
- DSS N/A
- Fundamental
- Price
- KZIA $6.51
- DSS $0.92
- Analyst Decision
- KZIA Strong Buy
- DSS
- Analyst Count
- KZIA 2
- DSS 0
- Target Price
- KZIA $57.50
- DSS N/A
- AVG Volume (30 Days)
- KZIA 2.6M
- DSS 188.9K
- Earning Date
- KZIA 07-07-2025
- DSS 08-12-2025
- Dividend Yield
- KZIA N/A
- DSS N/A
- EPS Growth
- KZIA N/A
- DSS N/A
- EPS
- KZIA N/A
- DSS N/A
- Revenue
- KZIA $1,549,158.00
- DSS $20,180,000.00
- Revenue This Year
- KZIA N/A
- DSS N/A
- Revenue Next Year
- KZIA N/A
- DSS N/A
- P/E Ratio
- KZIA N/A
- DSS N/A
- Revenue Growth
- KZIA 248983.08
- DSS 12.88
- 52 Week Low
- KZIA $2.86
- DSS $0.72
- 52 Week High
- KZIA $79.00
- DSS $1.74
- Technical
- Relative Strength Index (RSI)
- KZIA 49.53
- DSS 50.09
- Support Level
- KZIA $6.00
- DSS $0.86
- Resistance Level
- KZIA $9.60
- DSS $0.94
- Average True Range (ATR)
- KZIA 1.16
- DSS 0.07
- MACD
- KZIA -0.32
- DSS -0.00
- Stochastic Oscillator
- KZIA 15.84
- DSS 54.17
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.